TY - JOUR
T1 - Improvements and advances in core outcome set methodology
T2 - proceedings of the CS-COUSIN & COMFA Joint Meeting
AU - Dirr, McKenzie K.A.
AU - Alam, Murad
AU - Apfelbacher, Christian
AU - Drewitz, Karl Philipp
AU - Kang, Bianca Y.
AU - Munblit, Daniel
AU - Nekliudov, Nikita
AU - Seylanova, Nina
N1 - Funding Information:
The methodology for core outcome set development has continued to evolve over the past decade. Work has been done to produce core outcome sets that are inclusive and generalizable, and ensure the development process minimizes the introduction of the specific biases of the various stakeholders [, , , ]. In particular, the patient perspective is recognized as extremely important. Further advances in core outcome set methodology were discussed at the recent Cochrane Skin–Core Outcome Set Initiative (CS-COUSIN) and Core Outcome Measures in Food Allergy (COMFA) Initiative Joint Meeting, held virtually September 23 through 28, 2021 in Magdeburg, Germany ( https://cconline.eventsair.com/cs-cousin/ ) []. Both CS-COUSIN and COMFA are dedicated to the development of core outcome sets (COSs), which are standardized minimum outcomes for reporting findings from clinical trials and other studies within a given disease area [, ]. CS-COUSIN is an umbrella organization for COS groups which develop dermatological outcome sets, while the COMFA Initiative develops core outcomes related to food allergies [, , ]. COMFA is a COST Action (CA18227), which receives funding supported by COST (European Cooperation in Science and Technology, www.cost.eu ) []. The conference was jointly chaired by Professor Christian Apfelbacher (CS-COUSIN, co-chair of HOME and HECOS and grand holder scientific representative of COMFA) and Dr. Daniel Munblit (COMFA chair).
Funding Information:
Murad Alam is Editor-in-Chief of Archives of Dermatological Research. McKenzie A. Dirr has no conflicts of interest. Karl Philipp Drewitz has no conflicts of interest. Nikita Nekliudov and Nina Seylanova have no conflicts of interest. Christian Apfelbacher is Section Editor for Outcomes Research of BJD and co-chair of the HOME and HECOS initiatives. Further, he received institutional funding from the Dr Wolff Group, and consultancy fees from the Dr Wolff Group, Sanofi Genzyme, Sanofi-Aventis Deutschland and LeoPharma.
Publisher Copyright:
© 2022, The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
PY - 2022
Y1 - 2022
N2 - A COS is a systematically developed list of outcomes recommended for reporting all studies within a particular disease area. The Cochrane Skin–Core Outcome Set Initiative (CS-COUSIN) and the Core Outcome Measures in Food Allergy (COMFA) Initiative Joint Meeting was held virtually on September 23 through 28, 2021. This meeting brought together core outcome set (COS) developers within the domains of dermatology and food allergy, respectively. The meeting assessed the state of COS methodology, provided a forward look, and facilitated the networking of members of individual COS groups. The meeting hosted several expert-led key addresses and focus sessions, in which work was critically discussed, new developments were shared, and groundwork was laid for future projects. The conference emphasized the importance of ongoing COS work to improve patient outcomes and limit research waste.
AB - A COS is a systematically developed list of outcomes recommended for reporting all studies within a particular disease area. The Cochrane Skin–Core Outcome Set Initiative (CS-COUSIN) and the Core Outcome Measures in Food Allergy (COMFA) Initiative Joint Meeting was held virtually on September 23 through 28, 2021. This meeting brought together core outcome set (COS) developers within the domains of dermatology and food allergy, respectively. The meeting assessed the state of COS methodology, provided a forward look, and facilitated the networking of members of individual COS groups. The meeting hosted several expert-led key addresses and focus sessions, in which work was critically discussed, new developments were shared, and groundwork was laid for future projects. The conference emphasized the importance of ongoing COS work to improve patient outcomes and limit research waste.
KW - Core outcome set
KW - Development
KW - Methodology
KW - Proceeding
UR - http://www.scopus.com/inward/record.url?scp=85126032479&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85126032479&partnerID=8YFLogxK
U2 - 10.1007/s00403-022-02341-3
DO - 10.1007/s00403-022-02341-3
M3 - Article
C2 - 35244760
AN - SCOPUS:85126032479
JO - Archives of Dermatological Research
JF - Archives of Dermatological Research
SN - 0340-3696
ER -